Hannah Joseph Hospital Ltd. logo

Hannah Joseph Hospital Ltd. (HANNAH)

Market Closed
11 Aug, 22:00
MSE MSE
102. 85
+0.8
+0.7839%
2.27B Market Cap
- P/E Ratio
- Div Yield
6,000 Volume
- Eps
102.05
Previous Close
Add Transaction
Day Range
102.8 102.9
Year Range
55.99 128.8
Want to track HANNAH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HANNAH closed today higher at ₹102.85, an increase of 0.7839% from yesterday's close, completing a monthly decrease of -6.4149% or -₹7.05. Over the past 12 months, HANNAH stock gained 46.9286%.
HANNAH is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

HANNAH Chart

Hannah Joseph Hospital Ltd. (HANNAH) FAQ

What is the stock price today?

The current price is ₹102.85.

On which exchange is it traded?

Hannah Joseph Hospital Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is HANNAH.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.27B.

Has Hannah Joseph Hospital Ltd. ever had a stock split?

No, there has never been a stock split.

Hannah Joseph Hospital Ltd. Profile

- Industry
- Sector
- CEO
MSE Exchange
- ISIN
India Country
364 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Hannah Joseph Hospital Ltd. stands as a prominent multi-specialty healthcare provider located in Madurai, Tamil Nadu, India, operating a cutting-edge, 150-bed facility. Established in 2008, the hospital initially focused on developing a center of excellence in neurosurgery, neurology, psychiatry, and trauma care, establishing itself as a leading institution in neurosciences throughout South Tamil Nadu. Equipped with an advanced neuroradiology department that adheres to international standards, the hospital has continued to grow since its inception. In 2020, Hannah Joseph Hospital expanded to its current state-of-the-art campus, branching into cardiac sciences that included the establishment of a cath lab along with dedicated operating theaters designed for complex coronary angioplasties and open-heart surgeries.

Officially incorporated as a public limited company in 2011, the hospital made its debut on the Bombay Stock Exchange (BSE) following a successful ₹42 crore Initial Public Offering (IPO) in January 2026. For the fiscal year 2025, its total operating revenue was recorded at ₹77.53 crore. The facility is led by Managing Director Mosesjoseph Arunkumar and employs a dedicated team of 364 staff members. With a steadfast commitment to innovation, clinical excellence, and ensuring patient safety, the hospital offers a comprehensive range of services in neurosciences, cardiac care, and trauma services, significantly impacting the regional community through its use of advanced medical technologies. Furthermore, its emerging role in the financial markets underscores the increasing opportunities within India’s healthcare sector.

Products and Services

  • Neurosurgery: Specializing in intricate surgical procedures addressing conditions of the brain, spine, and nervous system, utilizing the latest technological advancements and techniques to provide optimal patient outcomes.
  • Neurology: Comprehensive diagnostic and therapeutic services for neurological disorders, ensuring effective management of conditions such as epilepsy, multiple sclerosis, and stroke, supported by specialized staff trained in advanced neurological care.
  • Psychiatry: Offering a range of mental health services, the psychiatric department provides diagnosis, treatment, and counseling for various mental illnesses, emphasizing a multidisciplinary approach for holistic patient care.
  • Trauma Care: Equipped to handle emergency situations, the trauma care unit caters to severe injuries with prompt interventions, including life-saving surgeries and critical care management.
  • Cardiac Sciences: Featuring a fully equipped cardiac department that includes a cath lab for diagnostic and interventional procedures, as well as specialized operating theaters designed for complex open-heart surgeries and coronary angioplasties.
  • Neuroradiology: The hospital’s neuroradiology department is renowned for its state-of-the-art imaging technologies that meet international standards, ensuring accurate diagnosis and treatment planning for neurological conditions.
  • Patient Safety Initiatives: A core focus of the hospital's operational philosophy, this involves employing advanced technologies and evidence-based practices to ensure the highest level of safety and care for all patients.

Contact Information

Address: Madurai-Tuticorin Ring Road
Phone: 91 95 2472 9594